rs750320097

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000639049.1(EPM2A):​n.*2531G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000707 in 707,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000071 ( 0 hom. )

Consequence

EPM2A
ENST00000639049.1 non_coding_transcript_exon

Scores

6
Splicing: ADA: 0.00004983
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.545

Publications

0 publications found
Variant links:
Genes affected
EPM2A (HGNC:3413): (EPM2A glucan phosphatase, laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018]
EPM2A Gene-Disease associations (from GenCC):
  • Lafora disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPM2ANM_005670.4 linkc.*1691G>A 3_prime_UTR_variant Exon 4 of 4 ENST00000367519.9 NP_005661.1 O95278-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPM2AENST00000367519.9 linkc.*1691G>A 3_prime_UTR_variant Exon 4 of 4 1 NM_005670.4 ENSP00000356489.3 O95278-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000208
AC:
5
AN:
240478
AF XY:
0.0000308
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000459
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000707
AC:
5
AN:
707662
Hom.:
0
Cov.:
9
AF XY:
0.00000789
AC XY:
3
AN XY:
380016
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
18964
American (AMR)
AF:
0.0000231
AC:
1
AN:
43198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21378
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36284
South Asian (SAS)
AF:
0.00
AC:
0
AN:
69844
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52850
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4326
European-Non Finnish (NFE)
AF:
0.00000941
AC:
4
AN:
425200
Other (OTH)
AF:
0.00
AC:
0
AN:
35618
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000268), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.395
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cataract;C1837397:Severe global developmental delay;C4551563:Microcephaly Uncertain:1
Jan 01, 2017
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.7
DANN
Benign
0.60
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.032
N
PhyloP100
0.55
GERP RS
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000050
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750320097; hg19: chr6-145946861; API